Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.54
-1.09 (-2.00%)
At close: Nov 4, 2024, 4:00 PM
53.75
+0.21 (0.39%)
After-hours: Nov 4, 2024, 7:55 PM EST
Moderna Market Cap
Moderna has a market cap or net worth of $20.58 billion as of November 4, 2024. Its market cap has decreased by -34.35% in one year.
Market Cap
20.58B
Enterprise Value
11.04B
1-Year Change
-34.35%
Ranking
Category
Stock Price
$53.54
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.03B to $20.58B, an increase of 241.08%. That is a compound annual growth rate of 23.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 21.00B | -44.62% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | 6.52B | 31.58% |
| Dec 31, 2018 | 4.95B | -17.90% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| West Pharmaceutical Services | 22.92B |
| STERIS | 22.21B |
| BeiGene | 21.70B |
| Zimmer Biomet Holdings | 21.35B |
| The Cooper Companies | 21.08B |
| Teva Pharmaceutical | 20.90B |
| Hologic | 19.12B |
| Labcorp Holdings | 18.99B |